Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IONIS APO(a)-LRx in Healthy Volunteers With Elevated Lipoprotein(a)

NCT02414594 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Elevated Lipoprotein(a)

Interventions

DRUG: IONIS-APO(a)-LRx
DRUG: Sterile Normal Saline (0.9% NaCl)

Sponsor

Ionis Pharmaceuticals, Inc.

Collaborators

[object Object]